Literature DB >> 20411094

Fournier gangrene.

Chelsea T Wolf1, Stephen J Wolf.   

Abstract

Entities:  

Year:  2010        PMID: 20411094      PMCID: PMC2850836     

Source DB:  PubMed          Journal:  West J Emerg Med        ISSN: 1936-900X


× No keyword cloud information.
A 51-year-old male with hepatitis C and a history of intravenous (IV) drug use presented to the emergency department, reporting one day of worsening scrotal pain and swelling. He denied diabetes, trauma, or infection with HIV. His genitourinary examination revealed a draining lesion in his left inguinal region with surrounding induration and cellulitis extending onto his perineum. His scrotum was enlarged, edematous, and tender with a distinct region of ecchymosis (Figure). A calculated Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was 7, indicating a moderate risk for necrotizing soft tissue infection (NSTI).1 Shortly after arrival, the patient was transferred to the operating room for surgical debridement, where the diagnosis of Fournier’s gangrene was confirmed.
Figure.

A draining lesion in his left inguinal region with surrounding induration and cellulitis extending onto his perineum with enlarged, edematous scrotum.

Fournier gangrene is a rapidly-spreading NSTI of the perineum causing fascial and subcutaneous tissue destruction, with mortality rates of 17% to 34%.2 Risk factors for NSTIs and Fournier gangrene include diabetes, IV drug use, trauma, recent surgery, immune suppression (e.g., cirrhosis or malignancy), peripheral vascular disease, and morbid obesity.2,3 Fournier gangrene is classically associated with eccymotic changes, edema, erythema, and drainage from wounds. These findings, however, tend to arise late in the disease process. Early indicators that must heighten a clinician’s suspicion include severe genital pain and tenderness in the absence of external signs. Multiple laboratory markers have been suggested as useful in diagnosing NSTIs.1,4 The LRINEC score (See Table) is a weighted point system of such markers often used to stratify patients into low, moderate, or high risk for NSTIs.1
Table.

Laboratory Risk Indicator for Necrotizing Fasciitis Score

VariableValuePoints
C-Reactive Protien (mg/L)< 1500
≥ 1504
WBC (cells/mm3)< 150
15–251
> 252
Hemoglobin (g/dL)> 13.50
11–13.51
< 112
Serum sodium (mmol/L)≥ 1350
< 1352
Serum creatinine (mg/dL)≤ 1.60
> 1.62
Plasma glucose (mg/dL)≤ 1800
> 1802
RiskProbabilityTotal Score

Low< 50%≤ 5
Moderate50–75%6–7
High> 75%≥ 8
  3 in total

Review 1.  Necrotizing soft-tissue infection: diagnosis and management.

Authors:  Daniel A Anaya; E Patchen Dellinger
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

2.  A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection.

Authors:  D B Wall; S R Klein; S Black; C de Virgilio
Journal:  J Am Coll Surg       Date:  2000-09       Impact factor: 6.113

3.  The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections.

Authors:  Chin-Ho Wong; Lay-Wai Khin; Kien-Seng Heng; Kok-Chai Tan; Cheng-Ooi Low
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

  3 in total
  1 in total

Review 1.  Contemporary diagnosis and management of Fournier's gangrene.

Authors:  Avinash Chennamsetty; Iyad Khourdaji; Frank Burks; Kim A Killinger
Journal:  Ther Adv Urol       Date:  2015-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.